RGC
NASDAQ 已收盘Regencell Bioscience Holdings Limited
6.05 USD
▼-0.05-1.31%
盘后 6.30 +2.77%
2026-08-03
市值
$3.00B
市盈率
—
EPS
-0.01
股息率
—
52 周区间
4.51 – 69.00
成交量
231.89K
Beta
1.49
目标价
—
52W 低 4.5152W 高 69.00
价格走势
公司简介
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.